title: Implication of caspases during maedi-visna virus-induced apoptosis.
abstract: Maedi-visna virus (MVV) causes encephalitis, pneumonia and arthritis in sheep. In vitro, MVV infection and replication lead to strong cytopathic effects characterized by syncytia formation and subsequent cellular lysis. It was demonstrated previously that MVV infection in vitro induces cell death of sheep choroid plexus cells (SCPC) by a mechanism that can be associated with apoptotic cell death. Here, the relative implication of several caspases during acute infection with MVV is investigated by employing diverse in vitro and in situ strategies. It was demonstrated using specific pairs of caspase substrates and inhibitors that, during in vitro infection of SCPC by MVV, the two major pathways of caspase activation (i.e. intrinsic and extrinsic pathways) were stimulated: significant caspase-9 and -8 activities, as well as caspase-3 activity, were detected. To study the role of caspases during MVV infection in vitro, specific, cell-permeable, caspase inhibitors were used. First, these results showed that both z-DEVD-FMK (a potent inhibitor of caspase-3-like activities) and z-VAD-FMK (a broad spectrum caspase inhibitor) inhibit caspase-9, -8 and -3 activities. Second, both irreversible caspase inhibitors, z-DEVD-FMK and z-VAD-FMK, delayed MVV-induced cellular lysis as well as virus growth. Third, during SCPC in vitro infection by MVV, cells were positively stained with FITC-VAD-FMK, a probe that specifically stains cells containing active caspases. In conclusion, these data suggest that MVV infection in vitro induces SCPC cell death by a mechanism that is strongly dependent on active caspases.
authors.affiliation: Laboratoire de Microbiologie, Faculté de Pharmacie, 2 rue du Dr Marcland, 87025 Limoges Cedex, France1.
authors.forename: R
authors.initials: R
authors.lastname: Duval
authors.affiliation: Laboratoire de Microbiologie, Faculté de Pharmacie, 2 rue du Dr Marcland, 87025 Limoges Cedex, France1.
authors.forename: V
authors.initials: V
authors.lastname: Bellet
authors.affiliation: Laboratoire de Microbiologie, Faculté de Pharmacie, 2 rue du Dr Marcland, 87025 Limoges Cedex, France1.
authors.forename: S
authors.initials: S
authors.lastname: Delebassée
authors.affiliation: Laboratoire de Microbiologie, Faculté de Pharmacie, 2 rue du Dr Marcland, 87025 Limoges Cedex, France1.
authors.forename: C
authors.initials: C
authors.lastname: Bosgiraud
mesh_terms: D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D000818:Animals; D017209:Apoptosis; D061945:Caspase Inhibitors; D020169:Caspases / Q000378:metabolism*; D002478:Cells, Cultured; D002831:Choroid Plexus / Q000166:cytology / Q000821:virology*; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D003588:Cytopathogenic Effect, Viral; D009842:Oligopeptides / Q000494:pharmacology; D012756:Sheep; D014790:Visna-maedi virus / Q000472:pathogenicity* / Q000502:physiology
chemical_list: D000590:Amino Acid Chloromethyl Ketones; D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors; D009842:Oligopeptides; C110772:benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone; C096713:benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone; D020169:Caspases